DRUG · Mapped RxNorm record
tamoxifen
Normalized identity: tamoxifenView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
NCT00295646
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
anastrozole
Normalized identity: anastrozoleView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
zoledronic acid
Normalized identity: zoledronic acidView linked drug · Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
goserelin
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedTamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
tamoxifenDRUG · verified · RxNorm: tamoxifen
anastrozoleDRUG · verified · RxNorm: anastrozole
zoledronic acidDRUG · verified · RxNorm: zoledronic acid
goserelinOTHER
Sponsors & collaborators
Austrian Breast & Colorectal Cancer Study Grouplead sponsor
AstraZenecacollaborator
Novartis Pharmaceuticalscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00295646 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.